Ex vivo reversal of chemoresistance by tariquidar (XR9576).
Di Nicolantonio F, Knight LA, Glaysher S, Whitehouse PA, Mercer SJ, Sharma S, Mills L, Prin A, Johnson P, Charlton PA, Norris D, Cree IA.
Di Nicolantonio F, et al. Among authors: mercer sj.
Anticancer Drugs. 2004 Oct;15(9):861-9. doi: 10.1097/00001813-200410000-00006.
Anticancer Drugs. 2004.
PMID: 15457126